drugset / Trial / NCT01563289

Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries

NCT01563289

Phase 3 Completed 62 enrolled Orion Corporation, Orion Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study is to evaluate the efficacy and safety of Ibuprofen in patients with ankle injuries.

Timeline

Start
2012-02
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule

Indications

No indication recorded.